Mayne Pharma Intl Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for MAYNE PHARMA INTL, and what generic and branded alternatives to MAYNE PHARMA INTL drugs are available?
MAYNE PHARMA INTL has one approved drug.
Drugs and US Patents for Mayne Pharma Intl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma Intl | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 215775-001 | May 5, 2022 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mayne Pharma Intl | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 215775-003 | May 5, 2022 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mayne Pharma Intl | DILTIAZEM HYDROCHLORIDE | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 215775-002 | May 5, 2022 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.